Podcast Summary: "How David Fajgenbaum Saved His Own Life — and Thousands of Others"
Podcast Information:
- Title: Worklife with Adam Grant
- Host: Adam Grant
- Guest: Dr. David Fajgenbaum
- Release Date: March 25, 2025
- Produced by: TED in partnership with Transmitter Media
Introduction
In this compelling episode of Worklife with Adam Grant, organizational psychologist Adam Grant interviews Dr. David Fajgenbaum, a physician-scientist at Penn and the founder of the nonprofit EveryCure. Dr. Fajgenbaum shares his extraordinary journey of repurposing drugs to save his own life from a rare inflammatory disease and, subsequently, thousands of others. This conversation delves deep into the intersections of medicine, innovation, and personal resilience.
David Fajgenbaum’s Personal Journey to Survival
Battling Castleman's Disease
Dr. Fajgenbaum recounts his harrowing battle with Castleman's disease, a rare inflammatory condition that attacks vital organs. At just 25 years old and a third-year medical student, he faced multiple life-threatening relapses, leading him to take unprecedented steps to save himself.
[02:44] David Fajgenbaum: "I was a third-year med student, and I became critically ill with this horrible disease called Castleman's. I even had my last rites read to me because I was getting so sick... I discovered one [drug], and it saved my life."
Self-Experimentation and Discovery
Faced with limited treatment options, Dr. Fajgenbaum took the bold step of testing drugs on himself. This self-experimentation led to the discovery of a drug that not only halted his decline but also provided a pathway to recovery.
[03:22] David Fajgenbaum: "I was going to dedicate the rest of my life... to trying to see if I can find a drug for this disease."
Founding EveryCure: Repurposing Drugs for Broader Impact
Mission and Vision
Inspired by his own survival, Dr. Fajgenbaum founded EveryCure, a nonprofit organization focused on repurposing existing drugs to treat rare diseases. The goal is to identify and implement effective treatments that are often overlooked due to financial disincentives in the pharmaceutical industry.
[10:13] David Fajgenbaum: "It's the mission."
Leveraging Artificial Intelligence
EveryCure employs an AI-driven platform to analyze vast amounts of medical data, assessing 75 million drug-disease combinations to identify potential repurposing opportunities. This approach significantly reduces the time and resources required to discover effective treatments.
[19:05] David Fajgenbaum: "We utilize an AI platform that literally looks across all of the world's medical knowledge and gives us a score from 0 to 1 for all 75 million possibilities."
Overcoming Challenges: Functional Fixedness and Financial Barriers
Breaking Functional Fixedness
Dr. Fajgenbaum emphasizes the importance of looking beyond traditional uses of drugs. By challenging the cognitive bias of functional fixedness, EveryCure identifies novel applications for existing medications.
[14:52] David Fajgenbaum: "We always think about the first use and we oftentimes prevent ourselves from thinking creatively with these other uses."
Navigating Financial Incentives
The primary barrier to drug repurposing is the lack of financial incentives for pharmaceutical companies to invest in rare or inexpensive treatments. EveryCure addresses this by operating as a nonprofit, allowing them to pursue medically necessary treatments regardless of profitability.
[16:10] David Fajgenbaum: "We are a nonprofit, we don't need to profit. So we are actually going to pursue the non-profitable opportunities."
Impact and Success Stories
Saving Lives Through EveryCure
Since its inception, EveryCure has successfully identified and implemented treatments that have saved thousands of lives. Notable cases include:
- Kyla: A young patient who spent a year in the ICU was treated with Ruxolitinib, saving her life and allowing her to pursue nursing school.
- Uncle with Angiosarcoma: Treated with Pembrolizumab, extending his life by nine years.
[10:59] David Fajgenbaum: "It's hard to quantify. But certainly in the thousands."
Expanding Beyond Personal Success
The success of these treatments has motivated Dr. Fajgenbaum to expand EveryCure’s mission, focusing on finding and implementing more repurposed drugs to address various rare diseases.
[11:29] David Fajgenbaum: "We have to figure this thing out."
Strategic Approaches to Drug Repurposing
The Matrix: A Comprehensive Screening Tool
EveryCure's proprietary tool, referred to as the Matrix, assesses 4,000 approved drugs against 18,000 diseases. Initially processing 75 million combinations, the AI narrows down the possibilities to actionable opportunities.
[19:05] David Fajgenbaum: "We started the organization a couple of years ago... now we're down to about 17 hours to run the alpha algorithm."
Filtering for Impact
After AI screening, EveryCure applies strategic filters based on unmet medical needs, suffering severity, patient demographics, and drug affordability to prioritize the most impactful opportunities.
[20:03] David Fajgenbaum: "We have to decide what needs to be done next."
Balancing Passion and Practicality
Managing Personal and Organizational Demands
Dr. Fajgenbaum discusses the challenges of maintaining focus while ensuring flexibility within his team. He emphasizes the importance of a diverse team that can objectively evaluate and pivot based on data.
[26:37] David Fajgenbaum: "Having an amazing team that's empowered to be able to say... that's not what the data is telling us."
Avoiding Obsessive Passion
While Dr. Fajgenbaum is deeply passionate about his work, he acknowledges the need to balance dedication with personal relationships and team dynamics to prevent burnout and maintain effectiveness.
[24:38] David Fajgenbaum: "I've just always struggled with... you have to be able to switch in and out."
Future Directions and Broader Applications
Expanding the Scope of Repurposing
Dr. Fajgenbaum envisions EveryCure expanding its methodologies beyond drugs to other domains where repurposing can yield significant benefits. Examples include transforming technologies and reimagining existing tools for new uses.
[23:17] David Fajgenbaum: "We are really going to uncover so many treatments for so many diseases."
Collaborations with Pharmaceutical Companies
Recognizing the untapped potential in pharmaceutical data, Dr. Fajgenbaum advocates for partnerships between EveryCure and drug manufacturers to unlock and implement repurposed treatments efficiently.
[37:22] David Fajgenbaum: "We need to work hand in hand with pharmaceutical companies."
Personal Insights and Reflections
Creating Silver Linings
Inspired by his late mother, Dr. Fajgenbaum believes in not just finding positive outcomes but actively creating them through meaningful actions like founding EveryCure.
[28:41] David Fajgenbaum: "Creating a silver lining is saying... create an organization to fix this problem."
Advice and Learning
Dr. Fajgenbaum shares valuable career insights, emphasizing the importance of hope coupled with action and the benefits of pursuing challenging solutions for personal and team growth.
[34:33] David Fajgenbaum: "Hope is really important... hope should then turn into action."
Conclusion
This episode of Worklife with Adam Grant highlights Dr. David Fajgenbaum’s remarkable journey from battling a life-threatening disease to revolutionizing drug repurposing through EveryCure. His story underscores the power of innovation, resilience, and purposeful action in transforming personal tragedy into widespread medical advancements. Dr. Fajgenbaum’s work not only saves lives but also inspires a new paradigm in how we approach medical research and treatment accessibility.
Notable Quotes:
- David Fajgenbaum [02:44]: "I was the first patient I saved."
- Adam Grant [05:43]: "Every time I think about your story, I have this sense that you're just on a different plane of existence."
- David Fajgenbaum [28:41]: "Creating a silver lining is saying... create an organization to fix this problem."
- Adam Grant [35:12]: "If I can help someone who does [save lives], then that makes my work much more worthwhile."
Key Takeaways:
- Innovation through Repurposing: Leveraging existing drugs can provide rapid and cost-effective treatments for rare diseases.
- AI in Medical Research: Advanced AI platforms can analyze vast datasets to identify promising drug-disease combinations.
- Resilience and Purpose: Personal adversity can fuel groundbreaking contributions to society.
- Systemic Barriers: Financial incentives often hinder drug repurposing, necessitating nonprofit initiatives like EveryCure.
- Collaborative Potential: Partnerships between nonprofits and pharmaceutical companies could unlock further medical advancements.
Produced by Cosmic Standard for the TED Audio Collective.